When did ZEALAND PHARMA A/S (22Z.DE) report earnings last quarter?
ZEALAND PHARMA A/S (22Z.DE) last reported earnings on 2/19/2026.
ZEALAND PHARMA A/S (22Z.DE) Earnings History & Surprises
FRA:22Z • DK0060257814
Current stock price
37.56 EUR
-2.38 (-5.96%)
Last:
22Z.DE Earnings overview
Past quarterly earnings results for ZEALAND PHARMA A/S (22Z.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -DKK9.12
- Revenue Estimate
- 32.81M
Last Reported
Most Recent- Release Date
- Feb 19, 2026
- Period
- Q4 / 2025
- EPS Reported
- -DKK1.11
- EPS Surprise
- 86.60%
- Revenue Surprise
- -45.16%
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in DKK): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.11 | -8.29 | 86.60% | 73.06% | 69.05M | 125.92M | -45.16% | 662.48% |
| Q3 2025 | -5.75 | -8.26 | 30.39% | -52.52% | 49.569M | 34.05M | 45.58% | 1,022.74% |
| Q2 2025 | 107.61 | 113.92 | -5.54% | 2,404.28% | 9.088B | 9.421B | -3.53% | 26,527.65% |
| Q1 2025 | -4.75 | -0.66 | -623.12% | -28.03% | 8.092M | 31.865M | -74.61% | -46.37% |
| Q4 2024 | -4.12 | -5.37 | 23.23% | 6.58% | 9.056M | 24.864M | -63.58% | -61.02% |
| Q3 2024 | -3.77 | -3.63 | -4.00% | -406.50% | 4.415M | 55.866M | -92.10% | -98.51% |
| Q2 2024 | -4.67 | -4.09 | -14.25% | 15.09% | 34.131M | 13.043M | 161.68% | 227.96% |
| Q1 2024 | -3.71 | -4.28 | 13.40% | 1.33% | 15.089M | 9.301M | 62.23% | 10.72% |
| Q4 2023 | -4.41 | -3.93 | -12.15% | 33.28% | 23.235M | 10.113M | 129.75% | -2.88% |
| Q3 2023 | 1.23 | -2.37 | 151.87% | 138.32% | 295.517M | 59.088M | 400.13% | 576.02% |
| Q2 2023 | -5.50 | -4.79 | -14.85% | 50.18% | 10.407M | 12.508M | -16.80% | -71.37% |
| Q1 2023 | -3.76 | -3.80 | 1.17% | 27.13% | 13.628M | 7.217M | 88.83% | -9.61% |
| Q4 2022 | -6.61 | -5.87 | -12.60% | -1.85% | 23.925M | 14.534M | 64.61% | 78.12% |
| Q3 2022 | -3.21 | -5.30 | 39.48% | 30.37% | 43.714M | 43.86M | -0.33% | -19.33% |
| Q2 2022 | -11.04 | -7.71 | -43.17% | -60.70% | 36.347M | 54.444M | -33.24% | -0.55% |
| Q1 2022 | -5.16 | -6.75 | 23.58% | 10.73% | 15.077M | 64.928M | -76.78% | 164.32% |
| Q4 2021 | -6.49 | -6.48 | -0.20% | 33.50% | 13.432M | 82.777M | -83.77% | -78.80% |
| Q3 2021 | -4.61 | -6.28 | 26.59% | 19.97% | 54.188M | 71.741M | -24.47% | -4.14% |
| Q2 2021 | -6.87 | -6.28 | -9.47% | -337.58% | 36.547M | 63.757M | -42.68% | -83.46% |
| Q1 2021 | -5.78 | -6.29 | 8.16% | -16.06% | 5.704M | 63.276M | -90.99% | -54.06% |
| Q4 2020 | -9.76 | -5.57 | -75.33% | - | 63.356M | 108.01M | -41.34% | - |
| Q3 2020 | -5.76 | -5.38 | -7.10% | - | 56.526M | 78.799M | -28.27% | - |
| Q2 2020 | -1.57 | -0.86 | -82.52% | - | 221.016M | 204.99M | 7.82% | - |
| Q1 2020 | -4.98 | -4.99 | 0.22% | - | 12.416M | 16.32M | -23.92% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-127.91%
Max EPS beat (4)
86.60%
Min EPS beat (4)
-623.12%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-19.43%
Max Revenue beat (4)
45.58%
Min Revenue beat (4)
-74.61%
Analysis
In the last 4 quarters, 22Z.DE has beaten EPS estimates in 2 out of 4 releases
22Z.DE has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, 22Z.DE reported -127.9% below the EPS estimates on average.
In the last 4 quarters, 22Z.DE reported -19.4% below the revenue estimates on average.
Related analysis
ZEALAND PHARMA A/S / 22Z.DE Earnings FAQ
Did 22Z stock beat earnings estimates in the most recent quarter?
ZEALAND PHARMA A/S (22Z.DE) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often ZEALAND PHARMA A/S beats earnings estimates?
In the last 4 quarters, ZEALAND PHARMA A/S (22Z.DE) has beaten EPS estimates in 2 out of 4 releases.